Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy

PURPOSE: We investigated the clinical efficacy of immune checkpoint blocker (ICB) therapy for metastatic or advanced melanoma in Korean patients. As well, we assessed whether the effects of ICBs can be enhanced by combination therapy with palliative radiotherapy (RT). MATERIALS AND METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeongshim, Chang, Jee Suk, Roh, Mi Ryung, Jung, Minkyu, Lee, Choong-Kun, Oh, Byung Ho, Chung, Kee Yang, Koom, Woong Sub, Shin, Sang Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373866/
https://www.ncbi.nlm.nih.gov/pubmed/32054150
http://dx.doi.org/10.4143/crt.2019.598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373866/
https://www.ncbi.nlm.nih.gov/pubmed/32054150
http://dx.doi.org/10.4143/crt.2019.598

Ejemplares similares